Diaceutics Partners with Cornerstone AI to Elevate Laboratory Data Quality and Accelerate Precision Medicine Advances
Diaceutics
Jan 16, 2025, 09:00 ET
BELFAST, Northern Ireland and SAN FRANCISCO, Jan. 16, 2025 /PRNewswire-PRWeb/ -- Diaceutics, a leading technology and solutions provider to the life science industry, and Cornerstone AI, a leading AI-based data quality and data enhancement platform, today announced a strategic partnership to enhance the accuracy, completeness and usability of data from the DXRX laboratory network.
The collaboration integrates Cornerstone AI's proprietary lab data algorithms with Diaceutics' real-world data ecosystem, generating LOINC assignments to deliver faster, more accurate, and clinically meaningful insights. Laboratory data, often disjointed and inconsistent, remains a major hurdle in implementing precision medicine initiatives. By combining Cornerstone AI's advanced data quality and enhancement technology with Diaceutics' expertise in real-world data, the partnership addresses this challenge head-on improving overall data integrity. These advancements offer pharmaceutical, biotech, and diagnostics companies a stronger foundation for clinical development, faster market access, and better patient outcomes—delivering significant value across the healthcare ecosystem.
"Our laboratory data module will enable Diaceutics' to more efficiently resolve data inconsistencies and accelerate the development of targeted therapies—bringing vital treatments to patients faster." - Viraj Narayanan, CEO of Cornerstone AI
"Diaceutics' commitment to unlocking the potential of real-world data in advancing precision medicine aligns seamlessly with our mission," said Viraj Narayanan, CEO of Cornerstone AI. "Our laboratory data module will enable Diaceutics' to more efficiently resolve data inconsistencies and accelerate the development of targeted therapies—bringing vital treatments to patients faster."
"At Diaceutics, we understand that precision medicine success starts with precision in the data," said Scott Phillips, VP of Real-World Data at Diaceutics. "Our partnership with Cornerstone AI underscores our ongoing commitment to innovation in data quality, ensuring that the laboratory insights we provide are as accurate, complete, and clinically relevant as required to support the life sciences industry. High-quality data allows our clients to confidently reduce time-to-value, improve patient stratification, and deliver better patient outcomes."
Diaceutics and Cornerstone AI are at the forefront of real-world data analytics and precision medicine, empowering pharmaceutical and biotech stakeholders to glean more comprehensive insights from laboratory information. By delivering high-fidelity data that can be interpreted with greater confidence, the two organizations aim to advance patient-centric innovation and accelerate the delivery of critical treatments worldwide.
About Diaceutics
Diaceutics is a leading provider of precision medicine solutions, offering life sciences companies real-world data insights and expert guidance in diagnostic testing to optimize patient outcomes. By bridging the gap between biomarker testing and targeted therapies, Diaceutics empowers industry partners to succeed in the evolving field of personalized healthcare.
About Cornerstone AI
Founded by healthcare data scientists, Cornerstone AI's pioneering data quality platform is designed to unlock the power of clinical data. Cornerstone's AI-based solution learns the structure and relationships for any dataset, creates models for every data point leveraging what was learned, uses models to identify corrections for inconsistent data points, intelligently fills in missing data and exports clean data with a complete audit trail. Cornerstone AI enables organizations across the healthcare continuum to make faster, evidence-based decisions—enhancing patient care and driving scientific innovation.
Media Contact
Amber Moore, Moore Communications, 1 5039439381, amber@moorecom2.com